These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30780167)

  • 1. Plasma Concentrations of High Molecular Weight Kininogen and Prekallikrein and Venous Thromboembolism Incidence in the General Population.
    Folsom AR; Tang W; Basu S; Misialek JR; Couper D; Heckbert SR; Cushman M
    Thromb Haemost; 2019 May; 119(5):834-843. PubMed ID: 30780167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of plasma high molecular weight kininogen and prekallikrein and incidence of coronary heart disease, ischemic stroke and heart failure.
    Parikh RR; Folsom AR; Misialek JR; Rosamond WD; Chang PP; Tang W; Cushman M
    Thromb Res; 2019 Oct; 182():89-94. PubMed ID: 31473403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity.
    Reddigari SR; Kaplan AP
    Blood; 1989 Aug; 74(2):695-702. PubMed ID: 2752143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Plasma Kallikrein-Kininogen Pathway Is Critical in the Pathogenesis of Colitis in Mice.
    Wang B; Yang A; Zhao Z; He C; Liu Y; Colman RW; Dai J; Wu Y
    Front Immunol; 2018; 9():21. PubMed ID: 29467753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma kallikrein/kinin system: a revised hypothesis for its activation and its physiologic contributions.
    Schmaier AH
    Curr Opin Hematol; 2000 Sep; 7(5):261-5. PubMed ID: 10961574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis.
    Gallimore MJ; Harris SL; Jones DW; Winter M
    Thromb Res; 2004; 114(2):91-6. PubMed ID: 15306150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities.
    Schmaier AH
    J Thromb Haemost; 2016 Jan; 14(1):28-39. PubMed ID: 26565070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel anti-thrombotic mechanisms mediated by Mas receptor as result of balanced activities between the kallikrein/kinin and the renin-angiotensin systems.
    Fang C; Schmaier AH
    Pharmacol Res; 2020 Oct; 160():105096. PubMed ID: 32712319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor.
    Joseph K; Tholanikunnel BG; Kaplan AP
    J Allergy Clin Immunol; 2009 Jul; 124(1):143-9. PubMed ID: 19342086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High molecular weight kininogen interactions with the homologs prekallikrein and factor XI: importance to surface-induced coagulation.
    Mohammed BM; Sun MF; Cheng Q; Litvak M; McCrae KR; Emsley J; McCarty OJT; Gailani D
    J Thromb Haemost; 2024 Jan; 22(1):225-237. PubMed ID: 37813198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kallikrein-kininogen system activation and bradykinin (B2) receptors in indomethacin induced enterocolitis in genetically susceptible Lewis rats.
    Stadnicki A; Sartor RB; Janardham R; Stadnicka I; Adam AA; Blais C; Colman RW
    Gut; 1998 Sep; 43(3):365-74. PubMed ID: 9863482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.
    Steen Burrell KA; Layzer J; Sullenger BA
    J Thromb Haemost; 2017 Sep; 15(9):1807-1817. PubMed ID: 28632925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease.
    Merlo C; Wuillemin WA; Redondo M; Furlan M; Sulzer I; Kremer-Hovinga J; Binder BR; Lämmle B
    Atherosclerosis; 2002 Apr; 161(2):261-7. PubMed ID: 11888508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologic activities of the contact activation system.
    Schmaier AH
    Thromb Res; 2014 May; 133 Suppl 1(0 1):S41-4. PubMed ID: 24759141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Anabolic-Androgenic Steroid Abuse on the Contact Activation System.
    Sidelmann JJ; Gram JB; Palarasah Y; Rasmussen JJ; Kistorp C
    Thromb Haemost; 2021 Oct; 121(10):1268-1273. PubMed ID: 33401331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assembly and activation of the plasma kallikrein/kinin system: a new interpretation.
    Shariat-Madar Z; Mahdi F; Schmaier AH
    Int Immunopharmacol; 2002 Dec; 2(13-14):1841-9. PubMed ID: 12489798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleic acids as cofactors for factor XI and prekallikrein activation: Different roles for high-molecular-weight kininogen.
    Ivanov I; Shakhawat R; Sun MF; Dickeson SK; Puy C; McCarty OJ; Gruber A; Matafonov A; Gailani D
    Thromb Haemost; 2017 Apr; 117(4):671-681. PubMed ID: 28124063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyphosphate, Zn
    Wang Y; Ivanov I; Smith SA; Gailani D; Morrissey JH
    J Thromb Haemost; 2019 Dec; 17(12):2131-2140. PubMed ID: 31420909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.